Noninvasive Prenatal Paternity Testing (NIPP): How It Works
NIPP determines paternity during pregnancy using cell-free fetal DNA (cffDNA) in maternal blood.
Method
- Maternal blood draw (≥7–8 weeks gestation; cffDNA fraction ~4–10%).
- cffDNA isolated and sequenced (SNP microarray or NGS).
- Compared to alleged father's DNA (buccal swab).
- Bioinformatic analysis determines paternity probability.
Accuracy & Timing
- >99.9% accuracy for inclusion/exclusion.
- Possible from ~7 weeks; most labs require ≥8–9 weeks for reliable fetal fraction.
- Not affected by maternal medications or diet.
Advantages
- Noninvasive (no miscarriage risk vs. amnio/CVS).
- Early — first trimester.
- Safe for mother and fetus.
Limitations
- Cost: $800–$2,000+ (usually not insurance-covered).
- Cannot distinguish between identical twins.
- Low fetal fraction (obesity, early gestation) may yield inconclusive result.
- Legal chain-of-custody required for court admissibility.
Accredited labs (AABB) ensure quality. Results typically 5–10 business days.
Pregnancy & Health - Related Articles
- Missed Period? Possible Pregnancy Signs and Next Steps
- Early Pregnancy Symptoms: 8 Signs Before a Missed Period & When to Test
- Pregnancy Test Reusability: Accuracy & Health Risks Explained
- Postpartum Sex: When Is It Safe & What to Expect
- Pregnancy Cramps Without Bleeding: Causes & What to Expect
- Prenatal Supplements & Birth Defects: What You Need to Know
- Pregnancy Signs While Breastfeeding: What to Watch For
